| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 65026 |
mPEG-SA 甲氧基聚乙二醇丁二酸 |
137 |
h |
2025-02-14 |
| 65027 |
Boc-Pro-OMe ,CAS: 59936-29-7,淡黄色液体 |
164 |
axc |
2025-02-14 |
| 65028 |
mPEG-GA 甲氧基聚乙二醇戊二酸 |
133 |
h |
2025-02-14 |
| 65029 |
iRGD-PEG-DSPE 磷脂-聚乙二醇-iRGD |
138 |
h |
2025-02-14 |
| 65030 |
1,2-二棕榈酰基-SN-甘油-3-磷酸乙醇胺-N-丁二酰钠盐,186800-61-3 |
132 |
axc |
2025-02-14 |
| 65031 |
DSPE-PEG-iRGD 磷脂PEG多肽 |
112 |
h |
2025-02-14 |
| 65032 |
RGD-PEG-DSPE 磷脂PEG多肽 |
133 |
h |
2025-02-14 |
| 65033 |
DSPE-PEG-Alkyne,MW:3400 |
141 |
wyh |
2025-02-14 |
| 65034 |
1,2-二豆蔻酰-SN-甘油-3-磷酸单钠盐(DMPA),80724-31-8,磷脂酸类化合物 |
249 |
axc |
2025-02-14 |
| 65035 |
DSPE-PEG-OH,MW:3400 |
122 |
wyh |
2025-02-14 |
| 65036 |
DPPE-mPEG2000(铵盐),474922-84-4,白色或类白色粉末 |
129 |
axc |
2025-02-14 |
| 65037 |
DSPE-PEG-RGD 磷脂聚乙二醇多肽 |
123 |
h |
2025-02-14 |
| 65038 |
cRGD-PEG-DSPE 肿瘤靶向肽 |
114 |
h |
2025-02-14 |
| 65039 |
DSPE-PEG-PDP,MW:3400 |
123 |
wyh |
2025-02-14 |
| 65040 |
十三酸甘油三酯,26536-12-9,具有酯类化合物的典型化学性质 |
176 |
axc |
2025-02-14 |
| 65041 |
DSPE-PEG-RGD 脂质体修饰靶向穿膜肽RGD |
121 |
h |
2025-02-14 |
| 65042 |
NGR-PEG-DSPE 磷脂PEG肿瘤新生血管靶向肽 |
113 |
h |
2025-02-14 |
| 65043 |
DSPE-PEG-Estrogen,MW:3400 |
126 |
wyh |
2025-02-14 |
| 65044 |
(S)-1,2-二棕榈酰-sn-甘油醇(DPG),30334-71-5 |
171 |
axc |
2025-02-14 |
| 65045 |
DSPE-PEG-TAT 磷脂-聚乙二醇-穿膜肽TAT |
126 |
h |
2025-02-14 |
| 65046 |
DSPE-PEG-TAT 磷脂-聚乙二醇-穿膜肽TAT |
119 |
h |
2025-02-14 |
| 65047 |
1-硬脂酰-2-油酰-sn-甘油-3-磷酸单钠盐(SOPA-Na),384833-24-3,磷脂类化合物 |
149 |
axc |
2025-02-14 |
| 65048 |
DSPE-PEG-anisamide,MW:3400 |
118 |
wyh |
2025-02-14 |
| 65049 |
DSPE-PEG-Pemetrexed,MW:3400 |
161 |
wyh |
2025-02-14 |
| 65050 |
1-棕榈酰-2-亚油酰-sn-甘油-3-磷脂酰乙醇胺(PLinPE),26662-95-3 |
306 |
axc |
2025-02-14 |
| 65051 |
(S)-1,2-二硬脂酰-sn-甘油醇,10567-21-2 特点 |
185 |
axc |
2025-02-14 |
| 65052 |
DSPE-PEG-Raltitrexed,MW:3400 |
206 |
wyh |
2025-02-14 |
| 65053 |
2-(2-(2-氨基乙氧基)乙氧基)乙酸盐酸盐(AEEA盐酸盐),cas:134979-01-4 |
241 |
axc |
2025-02-14 |
| 65054 |
DSPE-PEG-Metronidazole,,MW:3400 |
151 |
wyh |
2025-02-14 |
| 65055 |
甲氧基聚乙二醇缩环氧丙烷,特点 |
152 |
axc |
2025-02-14 |
| 65056 |
DSPE-PEG-Ciprofloxacin,MW:3400 |
118 |
wyh |
2025-02-14 |
| 65057 |
PTP-PEG-DSPE 磷脂PEG胰腺癌靶向肽PTP |
124 |
h |
2025-02-14 |
| 65058 |
DSPE-PEG-cisplatin,MW:3400 |
109 |
wyh |
2025-02-14 |
| 65059 |
TH-PEG-DSPE 响应性穿膜肽TH-PEG-磷脂 |
108 |
h |
2025-02-14 |
| 65060 |
DSPE-PEG-DOX,MW:3400 |
156 |
wyh |
2025-02-14 |
| 65061 |
DSPE-PEG-Paclitaxel,MW:3400 |
156 |
wyh |
2025-02-14 |
| 65062 |
DSPE-PEG-PTP(KTLLPTP) 胰腺癌靶向肽 |
211 |
h |
2025-02-14 |
| 65063 |
DSPE-PEG-MTX,MW:3400 |
124 |
wyh |
2025-02-14 |
| 65064 |
DSPE-PEG-Dopamine,MW:3400 |
125 |
wyh |
2025-02-14 |
| 65065 |
PLGA-PEG-Biotin |
131 |
h |
2025-02-14 |
| 65066 |
DSPE-PEG-Comarin,MW:3400 |
124 |
wyh |
2025-02-14 |
| 65067 |
1,2-二硬脂酰-rac-甘油-3-甲氧基聚乙二醇5000,308805-39-2(PEG5000),具有双亲性结构的化合物 |
151 |
axc |
2025-02-14 |
| 65068 |
DSPE-PEG-Cy3,MW:3400 |
159 |
wyh |
2025-02-14 |
| 65069 |
PLGA-PEG-Biotin,Biotin-PEG-PLGA |
148 |
h |
2025-02-14 |
| 65070 |
DSPE-PEG-Ce6,MW:3400 |
270 |
wyh |
2025-02-14 |